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Abstract
The Indigenous population of the Northern Territory of Australia (NT) suffers from a very high burden of Streptococcus
pyogenes disease, including cardiac and renal sequelae. The aim of this study was to determine if S. pyogenes isolated from
this population represent NT endemic strains, or conversely reflect strains with global distribution. emm sequence typing
data were used to select 460 S. pyogenes isolates representing NT S. pyogenes diversity from 1987–2008. These isolates were
genotyped using either multilocus sequence typing (MLST) or a high resolution melting-based MLST surrogate (Minim
typing). These data were combined with MLST data from other studies on NT S. pyogenes to yield a set of 731 MLST or
Minim typed isolates for analysis. goeBURST analysis of MLST allelic profiles and neighbour-joining trees of the MLST allele
sequences revealed that a large proportion of the known global S. pyogenes MLST-defined diversity has now been found in
the NT. Specifically, fully sequence typed NT isolates encompass 19% of known S. pyogenes STs and 43% of known S.
pyogenes MLST alleles. These analyses provided no evidence for major NT-endemic strains, with many STs and MLST alleles
shared between the NT and the rest of the world. The relationship between the number of known Minim types, and the
probability that a Minim type identified in a calendar year would be novel was determined. This revealed that Minim types
typically persist in the NT for .1 year, and indicate that the majority of NT Minim types have been identified. This study
revealed that many diverse S. pyogenes strains exhibit global scale mobility that extends to isolated populations. The burden
of S. pyogenes disease in the NT is unlikely to be due to the nature of NT S. pyogenes strains, but is rather a function of social
and living conditions.
Citation: Towers RJ, Carapetis JR, Currie BJ, Davies MR, Walker MJ, et al. (2013) Extensive Diversity of Streptococcus pyogenes in a Remote Human Population
Reflects Global-Scale Transmission Rather than Localised Diversification. PLoS ONE 8(9): e73851. doi:10.1371/journal.pone.0073851
Editor: Igor Mokrousov, St. Petersburg Pasteur Institute, Russian Federation
Received April 24, 2013; Accepted July 23, 2013; Published September 16, 2013
Copyright:  2013 Towers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded in part by the by a National Health and Medical Research Council (Australia) Post-doctoral training fellowship awarded to RT
(Grant number 436034; http://www.nhmrc.gov.au/). No additional external funding was received for this study. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: phil.giffard@menzies.edu.au
¤ Current address: Peter Macauley Centre, Winnellie, Northern Territory, Australia
Introduction
The bacterium Streptococcus pyogenes is an important human
pathogen [1]. It is a common cause of pharyngitis (‘‘strep throat’’)
and skin infections. It can also cause invasive and systemic
infections that may be life threatening A distinctive aspect of S.
pyogenes infections is the rare but significant occurrence of immune
related sequelae. Acute rheumatic fever (ARF) is an inflammatory
condition that primarily affects the joints and the cardiac muscle
[2]. Repeated episodes of ARF can lead to rheumatic heart disease
(RHD) [1,3], which is associated with severe and sometime fatal
heart valve damage. Acute post-streptococcal glomerulonephritis
(APSGN) results from deposition of antibody-amtigen complexes
in the glomerula basement membrane, with consequent temporary
impairment of renal function. [4,5] ARF and RHD are largely
regarded as sequels of pharyngitis, and APSGN as a sequel of skin
infection. ARF, RHD and APSGN are all rare in developed
countries and are associated with high burdens of infection, and
sub-optimal provision of health care [1].
There is no vaccine available against S. pyogenes infections. The
diverse, immuno-dominant, antiphagocytic surface located M
protein can elicit M type specific immunity. However because of
the diversity of the M protein, this immunity can have limited
coverage of strains. Current vaccine development initiatives are
focussed either on multiple valency [6], or using conserved
domain(s) in the M proteins do elicity proader immunity [7].
The Australian Northern Territory (NT) is extraordinarily
sparsely populated. Two hundred and thirty-three thousand
people occupy 1.4 million km2, which is more than the areas of
Spain, Portugal, France and Great Britain combined. Thirty
percent of this population identify as Aboriginal, about half of
whom live in small Aboriginal communities, many of which are in
very remote locations. The NT Indigenous population is
disadvantaged with respect to most measures of health and
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socio-economic well-being. S. pyogenes-associated pyodermas (skin
sores) are very common in some communities, particularly in
children, often secondary to scabies infestation [8,9].
The north of the NT is mainly monsoonal tropical savannah. In
the Indigenous population of this zone, S. pyogenes pharyngitis
appears rare [10]. Despite this, this population has one of the
highest burdens of ARF and RHD in the world [2], which
challenges the dogma that S. pyogenes skin infections do not play a
role in these pathologies [10,11]. Paradoxically, in the southern
region of the NT, which is arid with low humidity, pyoderma rates
appear lower than in the northern region, pharyngitis is more
common, but the incidence of acute rheumatic fever and the
prevalence of rheumatic heart disease are similar to the tropical
north [11]. Post-streptococcal glomerulonephritis is also frequently
seen in the NT, with epidemics seen in the northern region and
sporadic cases in the south [12,13]. There is evidence that
streptococcal infections in childhood are a contributing factor to
the very high prevalence of renal failure in Indigenous adults [12].
S. pyogenes isolates from NT Aboriginal communities have been
characterized by emm sequence analysis [14,15,16], and in some
instances by multilocus sequence typing (MLST) [17,18]. The
emerging picture is that there is considerable genetic diversity.
Here we address the question as to whether this diversity reflects a
long history of S. pyogenes evolution within northern Australia prior
to European settlement, or conversely is a consequence of a more
recent ingress of multiple global S. pyogenes strains into the NT
Indigenous population, as has been suggested by Currie [19]. This
question is relevant with regards to both susceptibility of the local
population to infection for control of S. pyogenes disease by
vaccination using sequence-type specific vaccines [6].
Methods
Ethics Statement
This study made use of pure bacterial cultures that had
previously been collected in a variety of research projects involving
human subjects and from diagnostic service providers, and stored
frozen. This study involved no human experimentation or use of
previously unpublished human clinical data.
The S. pyogenes isolates used were all derived from the NT, and
stored at the Menzies School of Health Research in Darwin,
Australia. They were collected between 1987 and 2008 and were
either clinical isolates obtained from the Royal Darwin Hospital,
or collected in the course of research projects carried out in
Aboriginal communities emm sequence subtype data are available
for 1,732 of these isolates, and these encompass 104 emmST and
142 emm sequence subtypes.
Minim typing was performed as previously described [18].
Minim typing is based on MLST. [18,20,21,22]. The S. pyogenes
Minim typing system encompasses high resolution melting (HRM)
analysis of 10 stretches of DNA internal to the fragments used for
MLST. Each fragment encompasses a single nucleotide polymor-
phism (SNP) that is one part of a set derived from the S. pyogenes
MLST database on the basis of maximization of the Simpsons
Index of Diversity (D). Other SNPs in the fragments confer
additional resolving power. Minim data is interpreted by
converting the HRM curves to inferred G+C content. A current
key for converting between S. pyogenesMinim data and MLST data
is provided as supplementary data (Table S1). Minim types are
referred to as Melting Types (MelTs).,
MLST was performed as described by Enright and co-workers
[23], and the database accessed at http://spyogenes.mlst.net/.
Inference of population structures from MLST profiles using
goeBURST was performed as previously described by Francisco
and co-workers ( [24] and the software was accessed at http://
goeburst.phyloviz.net/.
Results
Four hundred and sixty isolates representing S. pyogenes diversity
in the NT were assembled by selecting one isolate from each year
for each emm sequence subtype. These were all subjected to Minim
typing. Where new MelTs, or new combinations of emmST and
MelT were observed, MLST was performed. These data were
combined with MLST data previously reported [17,18], and
MLST data extracted from 70 genome sequences currently under
analysis, the final result being 731 NT isolates with associated
Minim and/or MLST data. (Table S2). This included MLST data
for 400 isolates and Minim typing data for 491 isolates. The results
from the 156 isolates typed by both methods displayed 100%
concordance. In total, 121 MLST STs and 128 MelTs were
identified, including 45 new STs (ST572-ST617). The details of
200 isolates were deposited in the S. pyogenes MLST database at
http://spyogenes.mlst.net/.
The diversity of NT S. pyogenes MLST allele profiles within the
global context was visualised by goeBURST analysis ( [24],
http://goeburst.phyloviz.net/) (Fig 1, Table S3). As shown in
Fig 1, MLST STs found in the NT (shown in red and orange) are
distributed throughout the global S. pyogenes structure, with no
evidence for NT specific clonal complexes. All groups of .2 STs
linked by single locus variant (SLV) relationships were composed
either of NT and non-NT isolates or entirely of non-NT isolates,
with the mixed (NT plus non-NT isolates) groups being
numerically dominant. Therefore, we were unable to demonstrate
that any major strain or clonal complex has evolved extensively
and specifically within the NT, and conclude that the diversity
observed in the NT S. pyogenes population is not due to
diversification of endemic strains.
MLST allele sequence comparisons lead to a similar conclusion.
Neighbour-joining trees of all known alleles at each of the seven
MLST loci were assembled (Fig S1), and there is no evidence for
clustering of MLST alleles observed in the NT S. pyogenes isolates
(‘‘NT alleles’’). Alleles found in the NT represent 43% of all the
alleles in the MLST database. Fifty-four (23%) of NT alleles have
not been found elsewhere, but these are not clustered and 47 differ
at a single base and 6 differ at two bases from alleles found outside
Australia. The single remaining NT-specific allele, murI_73,
appears to be a chimera in part derived from Streptococcus
dysgalactiae subsp. equisimilis. murI_73 was found in two STs:
ST572 and ST588, which are single locus variants (SLVs) of each
other. ST572 is an SLV of ST166, which has been found in the
NT, the UK and The Gambia. ST572 and ST588 represent just
three of the 731 Menzies isolates with associated MLST and/or
Minim typing data, and the relevant emmSTs, emm77 (ST572 and
ST588), and stKNB1 (ST572) represent just 15 of the 1732 Menzies
isolates that have been subjected to emm analysis. Therefore, the
unusual murI-73 allele may represent an example of recombination
that has occurred within the NT, but it is not a marker of a
numerically significant NT-specific strain.
In order to estimate the depth of sampling of the NT S. pyogenes
population, we determined the relationship between the propor-
tion of MelTs identified in any given year that had been identified
in previous years, and the cumulative total number of MelTs
identified in the years preceding each year in question. Figure 2
demonstrates that the probability that a MelT identified in a
calendar year will have been previously identified rises markedly as
a function of the cumulative total of known MelTs. This indicates
S. pyogenes MLST Diversity in Northern Australia
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that a significant proportion of the total NT S. pyogenes diversity has
been identified.
Discussion
We have shown that S. pyogenes isolated from the sparse and
often isolated human population of the NT represents a
remarkably large subset of the known global S. pyogenes population
structure and diversity, as defined by MLST. We could find no
evidence for major S. pyogenes strains endemic to the NT. Previous
studies of NT S. pyogenes have revealed considerable diversity, and
it has been noted that similar emmSTs (sequence types based on a
portion of the M protein encoding emm gene) are found both in the
NT and elsewhere [16,25,26]. In contrast, a previous MLST-
based study of NT S. pyogenes indicated that there are many NT-
specific S. pyogenes STs. [17]. However our results show that this is
not the case, and that the results of McGregor and co-workers [17]
may be explained by their smaller sample size of NT isolates, and
the smaller size of the S. pyogenes MLST database at the time. Our
results are similar to what was found with paediatric S. pyogenes
isolates from Western Nepal, where 120 isolates encompassed 51
STs and 45 emm types, many of which had been identified
elsewhere [27]. Nine STs have been identified as occurring both in
Western Nepal and the NT: ST109, ST119, ST120, ST140,
Figure 1. GoeBURST highlighting NT strains (red=MLST data; orange=MLST inferred fromMinim typing and emmST). Grey circles or
sectors are STs thus far identified only outside the NT. Clonal complexes with NT isolates in two or more STs are circled. Each spot in the GoeBURST
diagram is labelled with an ST number. These may be visualised by zooming in.
doi:10.1371/journal.pone.0073851.g001
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ST181, ST267, ST289, ST297 and ST348, thus reinforcing the
global mobility of S. pyogenes. While the presence of S. pyogenes
disease in the NT Indigenous population prior to European
colonization cannot be completely excluded, this study provided
no evidence for this and is consistent with the notion that the
burden of S. pyogenes disease in the NT Indigenous population post-
dates European colonization [19].
There was sampling bias in our study, in that the 460 isolates
were selected for Minim typing on the basis of representing the
range of the emm subtype diversity in our collection. It is
conceivable that major core-genome defined S. pyogenes strain(s)
unique to the NT have been missed. However, in this and other
studies [17,18], 731 (42%) of the 1732 emm subtyped isolates from
the Menzies collection have now been subject to Minim typing
and/or MLST. For a numerically significant NT endemic strain to
remain undetected, all isolates of that strain would have to possess
the same emm subtype as isolate(s) already analysed by MLST and
or Minim typing, and also have not been analysed by MLST and
or Minim typing This is highly unlikely. Furthermore, a recent
study of NT S. pyogenes showed that the cumulative proportion of
isolates increases smoothly with the number of emm types,
indicating a lack of dominant strains [16]. While we cannot
disprove the existence of S. pyogenes strains unique to the NT, such
strains are at most rare.
The relationship between the number of known MelTs and the
probability that a MelT identified in a calendar year will be new,
suggests that the numerically significant S. pyogenes strains in the
NT have been identified. The line of best fit in Fig 2 indicates that
at the termination of sampling, ,80% of MelTs identified in a
calendar year had been identified in previous calendar years.
Therefore, a large proportion of the detected strains persist in the
NT for .1 year. We were unable to estimate the rate or dynamics
of strain turnover with greater accuracy, because the intensity and
locations of sampling varied from year to year. However, recent
outbreaks of streptococcal glomeronephritis in the NT, some
associated with known internationally circulating nephritic strains,
show that strain turnover has occurred within the period of sample
collection [13].
These findings support the view that the high burden of S.
pyogenes disease in the NT Indigenous population relates to
socioeconomic factors. It is well documented that remote
Indigenous communities have a much higher point prevalence
of streptococcal infection than the non-Indigenous population,
We therefore conclude that these communities which exhibit an
extremely high brurden of streptococcal disease are very efficient
at sampling form the global S. pyogenes population. This is most
likely a function of socioeconomic factors and limited access to
health care which long been known to contribute to streptococcal
transmission and disease [10]. Public health interventions that
target the prevalence of skin infections are likely to have the
greatest impact, at least in the tropical north of the NT. While
there is good evidence for outbreaks of acute post-streptococcal
glomerulonephritis in the NT [6], there is no discernable evidence
in the NT for an association between particular S. pyogenes strains
and rheumatic heart disease. In contrast to this, outbreaks of
rheumatic fever that have been observed in the United States
[28,29]. Our results suggest that the burden of rheumatic heart
disease in the NT Indigenous population is a simple function of the
magnitude of the burden of superficial S. pyogenes infection, possibly
modulated by a genetic component of host susceptibility [30].
Figure 2. The relationship between the cumulative total of already discovered MelTs, and the probability that a MelT identified in
any given calendar year will be not be novel. The line of best fit was calculated using a regression constrained to asymptote to a value#100%.
Its formula is y = 88.4((exp(0.582!623.18)/(1+exp(0.582!623.18)).
doi:10.1371/journal.pone.0073851.g002
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There is therefore little justification for interventions that target
any specific S. pyogenes strains, with the exception of known
nephritogenic strains. Consistent with this, current Northern
Territory Government mandated public health interventions
target eradication of nephritogenic clones with widespread use of
intramuscular benzathine penicillin (http://www.health.nt.gov.
au/library/scripts/objectifyMedia.aspx?file = pdf/10/84.
pdf&siteID= 1&str_title =Acute Post-Streptococcal Glomerulone-
phritis.pdf.).
The negative consequence of the diversity of NT S. pyogenes
upon the likely efficacy in the NT of an M-protein based vaccine
targeting only a subset of emm types in the NT [6] has already been
noted [16]. However, the significance of our study extends beyond
the NT by providing really good evidence for the rapid global
mobility of many S. aureus strains. This suggests that many, if not
all human populations, including those in developed countries,
may come in contact with considerable S. pyogenes diversity over
short time scales. This, in turn has the potential to facilitate
replacement of strains targeted by a vaccine by strains not targeted
by the vaccine.
In conclusion, the circumstances of the NT and the diverse
population structure iof NT S. pyogenes clearly indicate that
addressing social determinants and/or the use of an S. pyogenes
vaccine with broad specificity are the most promising strategies for
reducing the burden of S. pyogenes disease in the NT Indigenous
population,.
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Table S1 Key used to translate between Minim and
MLST data. This is a minor update of the key provided to
support the description of S. pyogenes Minim typing [18], and is
used in the same way.
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Table S2 Isolates included in this study, with emm
sequence subtype and MLST and/or Minim typing data.
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Table S3 MLST and/or Minim typing data, together
with geographic information, used to generate Fig 1.
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Figure S1 Neighbour joining trees of S. pyogenes MLST
loci. Red highlighted alleles have been found in the Australian
Northern Territory only. Yellow highlighted alleles have been
found in the Northern Territory and elsewhere. Non-highlighted
alleles have not been found in the Northern Territory.
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